18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors

Trial Profile

18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 15 Feb 2017

At a glance

  • Drugs F-18 fluorothymidine (Primary) ; Fluciclovine 18F (Primary)
  • Indications CNS cancer; Glioma; Tumours
  • Focus Diagnostic use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 15 Feb 2017 Last checked against ClinicalTrials.gov record.
    • 15 Feb 2017 Planned End Date changed from 1 Jan 2017 to 1 Jan 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top